Home > Healthcare > Medical Devices > Diagnostic Devices > Medical Imaging Phantoms Market

Medical Imaging Phantoms Market - By Product Type (X-ray, Ultrasound, MRI, Nuclear Imaging, CT), Material (Stimulating Devices, False Organs), End-use (Hospitals, Reference Laboratories, Research & Academic Institutes) – Global Forecast (2024 – 2032)

  • Report ID: GMI8854
  • Published Date: Apr 2024
  • Report Format: PDF

Medical Imaging Phantoms Market Size

Medical Imaging Phantoms Market size was valued at around USD 175.9 million in 2023 and is anticipated to register a CAGR of 5% between 2024 to 2032. Medical imaging phantoms are devices designed to mimic the properties of human tissues or organs when subjected to medical imaging technologies such as X-ray, ultrasound, MRI systems (Magnetic Resonance Imaging), CT (Computed Tomography), nuclear imaging, and others. These phantoms are used in the field of medical imaging to calibrate, standardize, and evaluate the performance of imaging systems.

The increasing healthcare infrastructure and investments is significant driving factors for the market. For instance, in March 2022, Gold Standard Phantoms participated in the 2022 P4 Precision Medicine Accelerator Program. Within this project, the company focused its investments on specialized phantoms designed for MRI imaging of human tissues and organs in living subjects. This program was overseen by University College London and Capital Enterprise and provided unparalleled access to expertise, valuable relationships, and opportunities for new connections.

Furthermore, growing prevalence of chronic diseases, rising adoption of medical imaging (market size is estimated to account for USD 67.6 billion by the end of year 2032), increasing demand for quality assurance, incorporation of artificial intelligence (AI) in medical imaging, government initiatives and funding, and increasing technological advancements, are the promoting factors fostering the growth of the market.

Medical Imaging Phantoms Market Trends

The growing prevalence of chronic diseases is a significant driver for market. These phantoms are essential tools for ensuring the accuracy and reliability of the diagnostic procedures associated with the diseases.

  • For instance, according to the World Health Organization (WHO), in 2024, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of people with epilepsy live in low- and middle-income countries. Further, it is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated.
  • Phantoms are valuable tools for training healthcare professionals in epilepsy imaging. They provide a realistic simulation of brain structures and abnormalities associated with the disease, allowing clinicians to practice interpreting images and identifying seizure foci.
  • For chronic conditions such as cancer, radiotherapy is a common treatment modality. Phantoms are used to optimize treatment plans by accurately measuring radiation dose delivery to tumors while minimizing exposure to surrounding healthy tissues. This is crucial for improving treatment outcomes and reducing side effects.
  • Thus, phantoms optimize treatment planning and monitoring, supports research and development of new imaging technologies, ensures regulatory compliance, and ultimately improves patient outcomes, thereby escalating the growth of the market.

Medical Imaging Phantoms Market Analysis

Medical Imaging Phantoms Market, By Product Type, 2021 – 2032 (USD Million)

Based on product type, the market is divided into x-ray phantoms, ultrasound phantoms, MRI phantoms, nuclear imaging phantoms, CT phantoms, and other product types. The x-ray phantoms segment is estimated to account for USD 90.9 million by 2032.

  • X-rays are used in a wide range of medical specialties, from general radiography to specialized fields such as orthopedics and dentistry. Each of these areas requires specific phantoms for calibration and quality assurance.
  • For instance, according to the National Library of Medicine, in 2022, x-ray phantoms such as the alderson radiation therapy (ART) phantom are utilized to simulate clinical scattered radiation impact in orthopedic procedures with measurements taken at different distances above the ground to represent specific body parts of orthopedists like knees, chest, and thyroid.
  • Further, these phantoms are vital for quality control and assurance programs in radiation dose management. Regular testing with phantoms helps to ensure that X-ray machines are functioning correctly and producing images with the desired contrast, resolution, and exposure levels.
  • Therefore, r-ray phantoms have a well-established market presence and are widely recognized and accepted by healthcare professionals and regulatory bodies. This stability and familiarity contribute to their dominance in the market.
Medical Imaging Phantoms Market, By Material (2023)

Based on material, the medical imaging phantoms market is bifurcated into stimulating devices and false organs. The stimulating device segment accounted for USD 116.6 million in 2023.


  • Stimulating devices generates electrical signals or simulate blood flow that are crucial for the development and validation of functional imaging techniques. For instance, the techniques such as functional MRI (fMRI) or PET imaging rely on measuring changes in blood flow or metabolic activity in response to stimuli.
  • Phantoms equipped with stimulating devices are used to simulate brain activity or responses in imaging studies. These phantoms can mimic the response of neural tissue to electrical or physiological stimuli, allowing researchers to validate imaging techniques and protocols.
  • Additionally, phantoms equipped with these devices are employed to confirm the functionality of nuclear imaging devices in conducting functional studies. Through the simulation of precise physiological responses these phantoms guarantee that imaging equipment can precisely detect and quantify alterations in brain activity.
  • Manufacturers offer phantoms with a range of stimulating devices that can be customized for specific research needs. This flexibility attracts researchers and institutions looking for tailored solutions for their functional imaging studies.

Based on end-use, the medical imaging phantoms market is segmented into hospitals, reference laboratories, research & academic institutes, and other end-users. The hospitals segment held a market share of 43.5% in the year 2023.

  • Hospitals are major consumers of medical imaging phantoms due to the high demand for diagnostic imaging services. They use a variety of imaging modalities such as X-ray, CT, MRI, ultrasound, and nuclear medicine for patient diagnosis and treatment planning.
  • Many hospitals are involved in research and development activities related to medical imaging. They use phantoms for developing and validating new imaging techniques, protocols, and technologies, especially in academic medical centers.
  • Hospitals often standardize their imaging procedures and equipment across departments for consistency and efficiency. Phantoms are used to establish and maintain these standards, ensuring uniformity in imaging practices.
  • Thus, the demand for medical imaging phantoms is continuous as hospitals perform imaging studies daily. This consistent demand from hospitals ensures a stable market for manufacturers and suppliers of phantoms, thereby augmenting the growth of the market.
North America Medical Imaging Phantoms Market, 2021 – 2032 (USD Million)

North America medical imaging phantoms market accounted for USD 71.3 million revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

  • The region is at the forefront of technological advancements in medical imaging. The countries invest heavily in research and development, leading to the introduction of cutting-edge imaging modalities and techniques. Medical imaging phantoms are essential for calibrating, testing, and validating these advanced imaging systems.
  • North America has a significant prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. The accurate diagnosis and treatment of these conditions require extensive use of medical imaging. As a result, there is a substantial demand for medical imaging phantoms in the region.
  • For instance, according to the National Library of Medicine, 1,958,310 new cancer cases and 609,820 cancer deaths occurred in the U.S. in 2023.
  • Further, the region has a well-developed healthcare education system including training programs for radiologic technologists, radiologists, and other healthcare professionals. Medical imaging phantoms are integral to these training programs, contributing to their high demand.

Medical Imaging Phantoms Market Share

The medical imaging phantoms industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive medical imaging phantoms for information management, precision medicine, and accurate diagnostics. This includes innovations such as higher resolution imaging, 3D/4D imaging, and functional imaging techniques and specialized phantoms for calibration, testing, and validation. Competition is driven by factors such as the quality and reliability of these phantoms, integration capabilities with existing phantoms, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Medical Imaging Phantoms Market Companies

Some of the eminent market participants operating in the medical imaging phantoms industry include:

  • BARTEC Top Holding GmbH
  • Carville Limited.
  • Gold Standard Phantoms
  • Ion Beam Applications SA.
  • Kyoto Kagaku Co., Ltd.
  • Leeds Test Objects
  • Mirion Technologies, Inc.
  • PTW Freiburg GmbH
  • Pure Imaging Phantoms
  • RSD Radiology Support Devices

Medical Imaging Phantoms Industry News:

  • In June 2023, Gold Standard Phantoms introduced development of the CARE phantom as part of the PREDICT project funded by grant from Horizon Europe's EIC Accelerator program. This installment widened the phantoms research and development and thereby stimulated the growth prospects and sales of the company.
  • In May 2022, IBA (Ion Beam Applications S.A.), announced that it has acquired Modus Medical Devices Inc., specialized in phantoms for quality assurance for radiation therapy. This acquisition strengthened the IBA portfolio and escalated the medical imaging phantoms segment. Thus, it increased the sales of the company.

The medical imaging phantoms market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

  • X-ray phantoms
  • Ultrasound phantoms
  • MRI phantoms
  • CT phantoms
  • Nuclear imaging phantoms
  • Other product types

Market, By Material

  • Stimulating devices
  • False organs

Market, By End-use

  • Hospitals
  • Reference laboratories
  • Research & academic institutes
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Medical imaging phantoms market size was USD 175.9 million in 2023 and is expected to reach over USD 270.2 million by 2032 owing to the increasing healthcare infrastructure and investments along with growing prevalence of chronic disorders worldwide.

Medical imaging phantoms industry from the x-ray phantoms segment is expected to record USD 90.9 million by 2032 due to their utilization in a wide range of medical specialties, from general radiography to specialized fields.

North America medical imaging phantoms industry expected to reach ISD 71.3 million by 2032 due to technological advancements in medical imaging and heavy investments in research and development in the region.

Gold Standard Phantoms, Ion Beam Applications SA., Kyoto Kagaku Co., Ltd., Leeds Test Objects, Mirion Technologies, Inc., PTW Freiburg GmbH, Pure Imaging Phantoms, and RSD Radiology Support Devices, are some of the major medical imaging phantoms companies worldwide.

Medical Imaging Phantoms Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 213
  • Countries covered: 22
  • Pages: 110
 Download Free Sample